KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235 | -39.0% | 16,904 | +0.9% | 0.00% | – |
| Q2 2023 | $385 | -37.8% | 16,756 | -19.8% | 0.00% | -100.0% |
| Q1 2023 | $619 | -8.3% | 20,891 | -22.7% | 0.00% | 0.0% |
| Q4 2022 | $675 | -99.9% | 27,038 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $588,000 | +10.7% | 27,031 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $531,000 | -53.5% | 26,953 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $1,142,000 | -26.6% | 26,996 | +10.2% | 0.00% | -50.0% |
| Q4 2021 | $1,555,000 | +16.9% | 24,493 | +8.2% | 0.00% | +100.0% |
| Q3 2021 | $1,330,000 | +10.2% | 22,636 | -9.0% | 0.00% | 0.0% |
| Q2 2021 | $1,207,000 | +223.6% | 24,877 | +159.1% | 0.00% | – |
| Q1 2021 | $373,000 | -23.9% | 9,600 | +21.5% | 0.00% | -100.0% |
| Q4 2020 | $490,000 | – | 7,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |